Ribavirin plus human leucocyte interferon alpha for the treatment of interferon resistant chronic hepatitis C: A controlled trial

Hepatology Research

Volumn 8, Issue 2, 1997, Pages 106-112

  Toccaceli, F ^a   Grimaldi, M ^b   Rosati, S ^a   Palazzini, E ^b   Laghi, V ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Alfa Wassermann SpA   (Italy)

Author keywords

Chronic hepatitis C; Human leukocyte interferon ; Non responder patients; Ribavirin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0030803648     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1386-6346(97)00056-9     Document Type: Article

References (17)

1. Fried MW, Hoofnagle JH. Therapy of Hepatitis C. Semin Liv Dis 1995;15:82-91.
2. Reichard O, Anderson J, Schvarcz R. Ribavirin treatment for chronic hepatitis C. Lancet 1991;337:1058-61.
3. Di Bisceglie AM, Shindo M, Fong TL, Fried MW, Swain MG, Bergasa NV, Axiotis CA, Waggoner JP, Park Y, Hoofnagle JH. A pilot study of Ribavirin therapy for chronic Hepatitis C. Hepatology 1992;16:649-54.
4. Hu KQ, Yu CH, Vierling JM. Direct detection of circulating Hepatitis C RNA using probes from the 5′ untranslated region. J Clin Invest 1992;89:2040-6.
5. Hawkins A, Davidson F, Simmonds P. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2 and 3 by Quantiplex HCV RNA assay versions 1 and 2, Roche monitor assay, and in-house limiting dilution method. J Clin Microbiol 1997;35:187-92.
6. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
7. Patterson JL, Fernandez-Larsson R. molecular mechanism of action of ribavirin. Rev Infect Dis 1990;12:1139-46.
8. Hall CB, McBride JT, Walsh EE, Bell DM, Gala CL, Hildreth S, Ecky LGT, Hall WJ. Aerosolized ribavirin treatment of infants with respiratory symcytial viral infection. N Engl J Med 1983;308:1443-5.
9. Camps J, Garcia N, Riezu-Boj JI, Civtera MP, Prieto J. Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon. J Hepatol 1993;19:408-12.
10. Brillanti S, Garson J, Foli M, Whitby K, Deaville R, Masci C, Miglioli M, Barbara L. A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastronterology 1994;107:812-7.
11. Schvarcz R, Yun ZB, Sonnerborg A, Weiland O. Combined treatment with interferon α-2b and ribavirin for chronic hepatitis C in patients with a previous non response or non-sustained response to interferon alone. J Med Virol 1995;46:43-7.
12. Martinot Peignoux M, Marcelein P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Lebreton V, Milotova V, Benhamou JP, Erlinger S. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 1995;22:1351-4.
13. Laghi V, Toccaceli F, Rosati S, Monini A, Grimaldi M, Foglianti G, Canova N, Palazzini E. Comparison of treatment with two different doses of leukocyte interferon α in patients with chronic hepatitis C. Hepatogastroenterology, 1997;44:31-35.
14. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-56.
15. Serejo F, Raimundo M, Marinho R, Gloria H, Velosa J, Ramalho F, Moura MC. The role of HCV genotypes and HCV-RNA in the long term response to alfa 2b interferon in chronic hepatitis C. J Hepatol 1997;26(suppl.1):228.
16. Lau JYN, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993;341:1501-4.
17. Hayden FG, Schlepushkin AN, Pushkarshava NL. Combined interferon-a2, rimantadine hydrochloride, and ribavirin inhibition of influenza virus replication in vitro. Antimicrob Agents Chemother 1984;25:53-7.